Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Creative Medical Technology Holdings, Inc./ 10-Q

Quarterly Report · 10-Q

Creative Medical Technology Holdings, Inc.

CELZNASDAQEQUITYCurrent

Quarterly Report

Filed Aug 7, 2026Accepted Aug 7, 2026, 5:23 PM EDTCIK 1187953Accession 0001477932-26-004779
View company →Permanent SEC source ↗
Share

Company context

We are a biotechnology company dedicated to the advancement of regenerative therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. Our platforms, therapies and products include the following:

Current securities

CELZNASDAQ · EQUITY · Current

Recent company filings

  1. Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesSep 25, 2026
  2. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security HoldersAug 31, 2026
  3. 424B3 filingAug 3, 2026
  4. EFFECT filingJul 31, 2026
  5. S-3 filingJul 24, 2026

As-filed source

Primary evidence
As filedOpen full document ↗